Ashley Hall's Net Worth
$165 Thousand
Who is Ashley Hall?
Ashley Hall does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Esperion Therapeutics, Inc., and Reneo Pharmaceuticals, Inc..
SEC CIK
Ashley Hall's CIK is 0001801842
Past Insider Trading and Trends
2021 was Ashley Hall's most active year for acquiring shares with 4 total transactions. Ashley Hall's most active month to acquire stocks was the month of December. 2023 was Ashley Hall's most active year for disposing of shares, totalling 2 transactions. Ashley Hall's most active month to dispose stocks was the month of July. 2023 saw Ashley Hall paying a total of $28,125.00 for 15,625 shares, this is the most they've acquired in one year. In 2023 Ashley Hall cashed out on 31,250 shares for a total of $98,057.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +45.16% | 7K |
—
|
—
| 22.5K |
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.43
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$4.04 | -$69,932.81 | 39.6K |
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |